Please log in to view this page
Username
Password
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
